ns 1608 has been researched along with nvp-ast487 in 1 studies
Studies (ns 1608) | Trials (ns 1608) | Recent Studies (post-2010) (ns 1608) | Studies (nvp-ast487) | Trials (nvp-ast487) | Recent Studies (post-2010) (nvp-ast487) |
---|---|---|---|---|---|
9 | 0 | 1 | 17 | 0 | 14 |
Protein | Taxonomy | ns 1608 (IC50) | nvp-ast487 (IC50) |
---|---|---|---|
Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.58 | |
Breakpoint cluster region protein | Homo sapiens (human) | 0.58 | |
Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.005 | |
Cyclin-dependent kinase-like 3 | Homo sapiens (human) | 0.0071 | |
MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | 1.76 | |
MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
1 other study(ies) available for ns 1608 and nvp-ast487
Article | Year |
---|---|
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |